Allele Biotechnology and Pharmaceuticals, Inc. v. Pfizer, Inc.

Good Law
United States District Court, Southern District of CaliforniaSeptember 13, 20213:20-cv-01958California833 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 ALLELE BIOTECHNOLOGY AND Case No.: 20-cv-01958-H-AGS PHARMACEUTICALS, INC., a 12 California corporation, ORDER DENYING DEFENDANTS’ MOTIONS TO COMPEL Plaintiff,

14 v. [Doc. Nos. 75, 76, 77, 78, 81, 82.] 15 PFIZER, INC., a Delaware corporation; BIONTECH SE, a German company; BIONTECH US, INC., a Delaware 17 corporation; and DOES 1-30, Defendants. 19 On September 1 and 2, 2021, the parties filed six joint filings for the determination of various discovery disputes. (Doc. Nos. 75, 76, 77, 78, 81, 82.) The Court held a hearing on the matter on September 13, 2021. Ben L. Wagner, Robert Schaffer, and Sushmitha Rajeevan appeared for Plaintiff Allele Biotechnology and Pharmaceuticals, Inc. Charles L. McCloud, Thomas H.L. Selby, Julie L. Tavares, and David J. Noonan appeared for Defendant Pfizer, Inc. Bruce M. Wexler, Elizabeth L. Brann, Merri C. Moken, and Karthik R. Kasaraneni appeared for Defendants…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.